Compugen (CGEN) Operating Margin (2009 - 2026)
Compugen (CGEN) reported Operating Margin of 414.38% for Q1 2026, up 4683.0% on a YoY basis from 8.66% in Q1 2025, and up 397.86% sequentially from 83.23% in Q4 2025.
Compugen (CGEN) Operating Margin (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 14 years of Operating Margin data on file, last reported at 414.38% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 4683.0% year-over-year to 414.38%; the trailing twelve-month figure through Mar 2026 stood at 43.97% (up 9830.0% YoY), and the FY2025 full-year result was 43.05%, up 9649.0% from the prior year.
- Operating Margin grew to 414.38% in Q1 2026, from 83.23% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 414.38% in Q1 2026 to a low of 2006.28% in Q2 2025.
- A 5-year average of 182.43% and a median of 26.24% in 2024 frame the typical range for Operating Margin.
- Peak annual rise in Operating Margin reached 59194 bps in 2025, while the deepest fall reached 170196 bps in 2025.
- Tracing CGEN's Operating Margin over 5 years: stood at 47.05% in 2022, then jumped by 214 bps to 53.75% in 2023, then tumbled by 1046 bps to 508.7% in 2024, then soared by 116 bps to 83.23% in 2025, then jumped by 398 bps to 414.38% in 2026.
- Business Quant data shows CGEN's Operating Margin at 414.38% in Q1 2026, 83.23% in Q4 2025, and 417.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 414.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 414.38% |
| Dec 31, 2025 | 83.23% |
| Sep 30, 2025 | -417.40% |
| Jun 30, 2025 | -2,006.28% |
| Mar 31, 2025 | 367.56% |
| Dec 31, 2024 | -508.70% |
| Sep 30, 2024 | 26.24% |
| Jun 30, 2024 | -304.33% |
| Mar 31, 2024 | 331.85% |
| Dec 31, 2023 | 53.75% |
| Dec 31, 2022 | -47.05% |
| Dec 31, 2020 | -454.55% |
| Sep 30, 2018 | -42.72% |
| Dec 31, 2016 | -16,484.91% |
| Sep 30, 2016 | -11,381.43% |
| Jun 30, 2016 | -1,412.90% |
| Mar 31, 2016 | -9,538.71% |
| Dec 31, 2015 | -8.75% |
| Sep 30, 2015 | -3,019.21% |
| Jun 30, 2015 | -3,117.94% |